2014
DOI: 10.1016/j.neuropharm.2013.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Effects of MK-801 treatment across several pre-clinical analyses including a novel assessment of brain metabolic function utilizing PET and CT fused imaging in live rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 58 publications
0
8
0
Order By: Relevance
“…Many of the pharmacological NMDAR hypofunction models utilize sub-chronic NMDAR antagonist administration of 5-7 days (Daya et al, 2014; Eyjolfsson et al, 2006; Hawken et al, 2013), or even shorter (Khella et al, 2014; Lopez-Gil et al, 2007; Manahan-Vaughan et al, 2008; Park et al, 2014) durations. In this study, we employed a 5-day NMDAR antagonist administration paradigm and found that it increased phosphorylation in the Akt/GS3K pathway, opposite to what we observed in SR−/− mice.…”
Section: Discussionmentioning
confidence: 99%
“…Many of the pharmacological NMDAR hypofunction models utilize sub-chronic NMDAR antagonist administration of 5-7 days (Daya et al, 2014; Eyjolfsson et al, 2006; Hawken et al, 2013), or even shorter (Khella et al, 2014; Lopez-Gil et al, 2007; Manahan-Vaughan et al, 2008; Park et al, 2014) durations. In this study, we employed a 5-day NMDAR antagonist administration paradigm and found that it increased phosphorylation in the Akt/GS3K pathway, opposite to what we observed in SR−/− mice.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, data fusion is the use of different modalities to infer complementary and more comprehensive results than obtained by a single modality. The fusion of structural and functional modalities has been the subject of many studies such as fusion of MRI/PET (Cho et al, 2011;Prato et al, 2011;Chen et al, 2014), MRI/SPECT (Li and Wang, 2012), and CT/PET (Daya et al, 2014). In most cases, the combined modalities provide more promising results compared with a single modality.…”
Section: Image Registration and Data Fusionmentioning
confidence: 99%
“…Impairment of working memory has previously been reported in NMDAR antagonist models, but the extension of the resultant deficits appears to be greatly dependent on the nature of the pharmacological approach [41,42,43]. The NOR test has consistently been used as a first screening for working memory [17] and significant deficits were reported for ketamine, MK-801 or PCP [43].…”
Section: Discussionmentioning
confidence: 99%